Sequencing a whole human genome is a specialist endeavor, “but it works extremely well for us, as we bring human health, genomics and medicine together in one very important message," said Illumina Inc.'s chief scientific officer David Bentley in a recent interview. Illumina is well known among the specialist audience, its systems having sequenced over 90% of the world’s sequenced DNA. More sites are adopting the technology to create an “ever-growing network.”
If genetic testing follows the trend of wearables, and becomes readily accessible, able to fill in all of the gaps, like phenotypes and medical indicators such as pulse and blood...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?
